The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.
After surgery for prostate cancer, Todd Elworthy’s PSA came back elevated. Radiation was advised as the next step and Elworthy looked into a Fred Hutch clinical trial and proton therapy. Though he ...
The blood-based test is intended to aid in the decision for prostate biopsy for men older than 50 with elevated PSA levels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback